Fair Value Measurements (Tables)

12 Months Ended

Jul. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Derivatives on Balance Sheet

The fair value of the Company’s derivative contracts, recorded on the Consolidated Balance Sheets, was as follows (in millions):

		Assets				Liabilities
		July 31,				July 31,
Instruments	Balance Sheet Location	2023		2022		2023		2022
Designated as hedging instruments
Foreign currency forward contracts	Other current assets, other long-term assets	$	0.6	$	0.3	$	0.1	$	2.7
Net investment hedges	Other current assets, other long-term assets and other long-term liabilities	3.6		8.2		—		—
Total designated		4.2		8.5		0.1		2.7
Not designated as hedging instruments
Foreign currency forward contracts	Other current liabilities	0.7		1.7		1.4		2.5
Total not designated		0.7		1.7		1.4		2.5
Total		$	4.9	$	10.2	$	1.5	$	5.2

Schedule of Company’s Contingent Consideration Obligations

A reconciliation of the fair value of the Company’s contingent consideration liability that use unobservable inputs was as follows (in millions):

Balance as of July 31, 2022	$	24.7
Issuances	—
Adjustments to fair value	0.3
Balance as of July 31, 2023	$	25.0
Maximum potential payout	$	30.7

Balance as of July 31, 2021	$	—
Issuances	24.6
Adjustments to fair value	0.1
Balance as of July 31, 2022	$	24.7
Maximum potential payout	$	30.7